Log In
Print
BCIQ
Print
Print this Print this
 

EGFR MASTR

  Manage Alerts
Collapse Summary General Information
Company Multiplicom N.V.
DescriptionSomatic mutation kit to identify mutations in exons 18-21 of the EGFR gene
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationCancer, Diagnostic
Indication DetailsIdentify mutations in exons 18-21 of the EGFR gene
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today